We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+3.56%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$21.3B
AUM Growth
+$580M
(+2.8%)
Cap. Flow
+$169M
Cap. Flow
% of AUM
0.79%
Top 10 Holdings %
Top 10 Hldgs %
35.94%
Holding
882
New
52
Increased
484
Reduced
289
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NGD
New Gold Inc
NGD
|
+$52.1M |
| 2 |
Veeva Systems
VEEV
|
+$37.6M |
| 3 |
UnitedHealth
UNH
|
+$36.1M |
| 4 |
ServiceNow
NOW
|
+$35.9M |
| 5 |
B
Barrick Mining
B
|
+$35.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$43.4M |
| 2 |
ESV
Ensco Rowan plc
ESV
|
+$38.4M |
| 3 |
Walt Disney
DIS
|
+$35.1M |
| 4 |
McKesson
MCK
|
+$34.8M |
| 5 |
Hershey
HSY
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 56.36% |
| 2 | Technology | 9.22% |
| 3 | Energy | 7.08% |
| 4 | Healthcare | 5.95% |
| 5 | Financials | 3.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
ExxonMobil
XOM
$650B
| $7.06M | 0.03% |
100,031
+6,235
| +7% | +$451K |
|
277
ICL Group
ICL
$6.58B
| $7.05M | 0.03% |
1,407,489
+8,985
| +0.6% | +$44.8K |
|
278
Novartis
NVS
$302B
| $7.05M | 0.03% |
81,129
-15,427
| -16% | -$1.39M |
|
279
Cencora
COR
$62B
| $6.97M | 0.03% |
84,651
-351,672
| -81% | -$30.2M |
|
280
JPMorgan Chase
JPM
$916B
| $6.85M | 0.03% |
58,191
+9,143
| +19% | +$1.03M |
|
|
ADAM
281
Adamas Trust
ADAM
$777M
| $6.83M | 0.03% |
280,467
+38,310
| +16% | +$943K |
|
282
Starbucks
SBUX
$119B
| $6.72M | 0.03% |
76,002
+666
| +0.9% | +$61.7K |
|
283
ConocoPhillips
COP
$144B
| $6.71M | 0.03% |
117,755
+1,216
| +1% | +$69.2K |
|
284
Arbor Realty Trust
ABR
$977M
| $6.7M | 0.03% |
511,053
+73,724
| +17% | +$921K |
|
|
SGEN
285
DELISTED
Seagen Inc. Common Stock
SGEN
| $6.68M | 0.03% |
78,277
+814
| +1% | +$59.7K |
|
286
CME Group
CME
$95.4B
| $6.6M | 0.03% |
31,213
+1,001
| +3% | +$209K |
|
287
Ventas
VTR
$47.5B
| $6.57M | 0.03% |
89,907
+6,113
| +7% | +$434K |
|
288
Goldman Sachs BDC
GSBD
$997M
| $6.55M | 0.03% |
326,129
+8,637
| +3% | +$173K |
|
289
Digital Realty Trust
DLR
$69.6B
| $6.54M | 0.03% |
50,385
+1,557
| +3% | +$189K |
|
290
Apple
AAPL
$4.97T
| $6.52M | 0.03% |
116,380
+3,672
| +3% | +$192K |
|
291
Duke Energy
DUK
$101B
| $6.48M | 0.03% |
67,612
+532
| +0.8% | +$48.4K |
|
292
Verizon
VZ
$197B
| $6.46M | 0.03% |
106,979
+9,459
| +10% | +$545K |
|
293
Colgate-Palmolive
CL
$74.8B
| $6.45M | 0.03% |
87,718
+4,550
| +5% | +$330K |
|
294
Takeda Pharmaceutical
TAK
$56.7B
| $6.42M | 0.03% |
372,972
-66,367
| -15% | -$1.15M |
|
295
Vale
VALE
$62.3B
| $6.38M | 0.03% |
554,642
+43,809
| +9% | +$531K |
|
296
Chubb
CB
$140B
| $6.37M | 0.03% |
39,437
+502
| +1% | +$77.7K |
|
297
Mastercard
MA
$498B
| $6.32M | 0.03% |
23,269
+738
| +3% | +$203K |
|
298
Ionis Pharmaceuticals
IONS
$8.93B
| $6.3M | 0.03% |
105,218
+1,336
| +1% | +$87.1K |
|
299
Charter Communications
CHTR
$17.3B
| $6.3M | 0.03% |
15,290
+478
| +3% | +$193K |
|
300
American Tower
AMT
$83.5B
| $6.28M | 0.03% |
28,397
+899
| +3% | +$196K |
|
Similar funds
DAM
VanEck Associates's Q3 2019 Portfolio in Review
As of Q3 2019, VanEck Associates held 882 positions worth $21.3B, up 2.8% from $20.8B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
VanEck Associates's Q3 2019 filing shows 52 new, 484 increased, 289 reduced and 51 closed positions. Its largest new stake was Veeva Systems: 234,351 shares worth $35.8M. The largest sale was Allergan plc, an estimated $43.4M.
By sector, the portfolio is most concentrated in Materials at 56% of assets, up from 55% a quarter earlier, followed by Technology and Energy.
- VanEck Associates's largest Q3 2019 buy was Veeva Systems: 234,351 shares worth $35.8M.
- VanEck Associates added most to New Gold Inc in Q3 2019, an estimated $52.1M increase.
- VanEck Associates's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $43.4M.
- VanEck Associates fully exited Ensco Rowan plc in Q3 2019, selling an estimated $38.4M.
- VanEck Associates's ten largest holdings make up 36% of its $21.3B portfolio in Q3 2019.
- VanEck Associates opened 52 new positions and closed 51 in Q3 2019.
- VanEck Associates's portfolio value rose 2.8% quarter-over-quarter to $21.3B.
Based on VanEck Associates's 13F filing for Q3 2019, filed 8 Nov 2019.